HitGen Stock Forecast for 2023 - 2025 - 2030
Updated on 05/18/2024
HitGen Stock Forecast and Price Target
The average price target for HitGen's stock of ¥16.00 recently provided by leading analysts would represent a 22.32% upside from its last closing price if reached. This potential increase is based on a high estimate of ¥16.00 and a low estimate of ¥16.00. If you're interested in 688222 stock, it's important to compare it to other companies in the industry.
22.32% Upside
HitGen Fair Value Forecast for 2023 - 2025 - 2030
HitGen's Price has decreased In the last four years, from ¥1.65 to ¥0.00 – a 100.00% drop. Analysts predict that HitGen's Fair Value will increase in the upcoming year, reaching ¥1.50. This would represent an increase of 100.00%. Over the next seven years, experts predict that HitGen's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 603259 Stock Forecast | WuXi AppTec | Buy |
18
|
¥44.90 | Buy/Sell | ¥121.48 | 41.16% |
| 2269 Stock Forecast | WuXi Biologics (Cayman) | Outperform |
8
|
HK$14.06 | Buy/Sell | HK$69.40 | 37.98% |
| 300347 Stock Forecast | Hangzhou Tigermed Consulting | Outperform |
18
|
¥56.99 | Buy/Sell | ¥95.38 | 18.28% |
| 300759 Stock Forecast | Pharmaron Beijing | Outperform |
16
|
¥22.22 | Buy/Sell | ¥37.14 | 16.25% |
| 1548 Stock Forecast | Genscript Biotech | Buy |
5
|
HK$12.38 | Buy/Sell | HK$3.96 | -68.98% |
HitGen Revenue Forecast for 2023 - 2025 - 2030
In the last three years, HitGen's Revenue has seen an increase, rising from ¥243.60M to ¥371.66M. This represents a growth of 52.57%. In the following year, 0 experts forecast HitGen's Revenue will decrease by 12.88%, to ¥323.80M. In 2030, professionals predict that HitGen's Revenue will decrease by 11.38%, to ¥329.37M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 688202 Stock Forecast | Shanghai Medicilon | Outperform |
16
|
¥40.01 | Buy/Sell | ¥0.00 | -100.00% |
| 603127 Stock Forecast | Joinn Laboratories(China)Co.,L... | Outperform |
18
|
¥16.90 | Buy/Sell | ¥24.44 | 17.16% |
| 603108 Stock Forecast | Shanghai Runda Medical Technol... | - |
17
|
¥16.86 | Buy/Sell | ¥20.75 | -100.00% |
.jpg)
HitGen Dividend per Share Forecast for 2023 - 2025 - 2030
In the last year, HitGen's Dividend per Share has seen a drop from ¥0.05 to ¥0.05 – a 0.00% decrease. According to 1 major analysts, HitGen's Dividend per Share will fall by 60.00% in the next year, reaching ¥0.02. Professionals believe that By 2030, HitGen's Dividend per Share will fall to ¥0.00– a 100.00% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1873 Stock Forecast | Viva Biotech Holdings | Buy |
12
|
HK$0.71 | Buy/Sell | HK$0.00 | 909.86% |
| 300725 Stock Forecast | PharmaBlock Sciences (Nanjing) | Buy |
15
|
¥32.89 | Buy/Sell | ¥58.00 | 21.62% |
| 688315 Stock Forecast | Novogene | Buy |
2
|
¥14.39 | Buy/Sell | ¥30.25 | 32.04% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 300404 Stock Forecast | Boji Medical Technology | Hold |
14
|
¥7.37 | Buy/Sell | ¥0.00 | -100.00% |
| 688068 Stock Forecast | Beijing Hotgen Biotech | - |
16
|
¥29.72 | Buy/Sell | ¥0.00 | -100.00% |
| TNBI Stock Forecast | Tanke Biosciences | - |
0
|
$0.13 | Buy/Sell | $0.00 | -100.00% |
HitGen EBITDA Forecast for 2023 - 2025 - 2030
HitGen's EBITDA has grown in the last three years, jumping from ¥60.54M to ¥72.56M – an increase of 19.85%. According to 2 analysts, HitGen's EBITDA will fall by 7.66% in the next year, reaching ¥67.00M. For the next seven years, the forecast is for EBITDA to grow by 49.58%.
HitGen EBIT Forecast for 2023 - 2025 - 2030
In the last three years, HitGen's EBIT has decreased from ¥41.68M to ¥35.14M – a 15.69% drop. In the next year, analysts are expecting an increase in EBIT, predicting it will reach ¥36.50M – an increase of 3.87%. The HitGen forecast is for EBIT to reach ¥172.00M or grow by 389.47%.
HitGen EPS Price Prediction Forecast for 2023 - 2025 - 2030
HitGen's EPS has decreased In the last four years, from ¥0.11 to ¥0.00 – a 100.00% drop. Analysts predict that HitGen's EPS will increase in the upcoming year, reaching ¥0.10. This would represent an increase of 100.00%. Over the next seven years, experts predict that HitGen's EPS will grow at a rate of 100.00%.
.jpg)